Guidelines for the clinical evaluation of antineoplastic drugs
Contributors: United States. Food and Drug Administration
Series: HHS (FDA) -- 81-3112; DHHS publication -- no. (FDA) 81-3112
Publisher: U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration; For sale by the Supt of Docs., U.S. G.P.O.
Published: 1981
Place of publication: Rockville, Md; Washington, D.C
Language: eng
Subjects: Drugs -- Testing; Antineoplastic agents -- Testing
Notes: Feb. 1981